Your Skinbooster treatment

Before you have any treatment with Restylane Skinboosters you will have a consultation. Make sure that you are well prepared. Think through all the questions you may have and what results you would like to achieve. We warmly recommend you to read through our Q&A section below to find out more about treatments with Restylane Skinboosters. 

The first step: Find your clinic

Christoph Martschin, dermatologist, Sweden, gives you his best advice on how to find a clinic and a healthcare practitioner that you can trust and be comfortable with. 

Treatment areas

Restylane Skinboosters gives hydration and smoothness to your face, neck, décolletage and hands. 

Refresh indications and treatment areas
Crow's feet
Forehead lines
Cheeks
Peri-oral lines
Neck
Accordion lines
Refresh indications and treatment areas
Crow's feet
Neck
Peri-oral lines
Accordion lines
Forehead lines
Cheeks

What to ask your practitioner 

Here are a few questions that we recommend you to ask your healthcare practitioner: 

•    What results can I expect from the treatment?
•    What happens during the treatment?
•    Could my medical history or previous treatments affect or prevent treatment?
•    Are there any side effects and precautions that I should know about?
•    Is there anything I should do before and after treatment?
•    Any other question you may have.

You will also find detailed information about treatment with Restylane Skinboosters in our FAQ section below. 

FREQUENTLY ASKED QUESTIONS

The most common side effects include treatment site reactions such as swelling, bruising, redness, pain and tenderness. These side effects generally disappear within one week after injection. You should discuss the potential treatment risks with your healthcare practitioner.

Restylane is manufactured by Galderma. Galderma is a pharmaceutical company with over 6,000 employees worldwide. The company specializes in dermatology and is present in more than 100 countries. To read more about Galderma visit About Galderma

REFERENCES

1 Gubanova EI et al. Poster presented at IMCAS 2015.; Streker M et al. J Drugs Dermatol 2013;12, 990-994.